Stem-cell trial starts in the UK

Monday 12 September 2011

Mesoblast Ltd of Australia has received clearance to start a Phase 2 trial of a new allogeneic stem-cell therapy in patients suffering acute heart attacks. The UK’s King’s College Hospital NHS Foundation Trust is one of the study sites.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom